Nisha Pandey

Unapproved Weight-Loss Drug Caused Hospitalisations In Ireland: What Is Retatrutide & Why Is It Risky?

Irish health authorities are warning people against using <span>retatrutide</span>, an experimental weight-loss drug that has led to multiple cases of hospitalisation after people obtained it outside legitimate clinical trials through unlawful sources.

The warning comes as demand for the drug has grown online, particularly through fitness networks. Despite retatrutide not yet being approved, the masses have been reported to obtain and administer it without medical supervision. 

Ireland's Health Service Executive (HSE) has reported patients presenting with serious side effects after taking the drug, including severe vomiting and kidney problems. 

Prof Donal O'Shea, HSE Clinical Lead for Obesity, said doctors are seeing patients who have taken <a href="https://www.healthandme.com/health-news/entirely-unverified-retatrutide-being-sold-on-black-market-lilly-sues-6-companies-article-155602507" data-type="tilCustomLink">retatrutide</a> obtained through unofficial channels. 

He said, "Personal trainers who have been giving these jabs give no advice about side effects and how to manage those side effects, leading to real problems".

He also warned that some people are choosing not to disclose this information to the healthcare professionals, which has been making it harder to identify the cause of their symptoms and administer appropriate treatment. 

He added, “They are too embarrassed to say they are taking it, leaving us blindfolded when we are trying to come to a conclusion.”

<h2>Retatrutide Is An Unapproved Experimental Drug </h2>

Also read: <a href="https://www.healthandme.com/health-news/uk-approves-eli-lillys-foundayo-is-the-glp-1-pill-better-than-wegovy-mounjaro-article-155531919" data-type="tilCustomLink">Eli Lilly’s Foundayo Launched In UK: Is the GLP-1 Pill Better Than Wegovy, Mounjaro?</a>

Retatrutide is currently being developed by <a href="https://www.healthandme.com/health-news/eli-lilly-roches-alzheimers-blood-test-gets-fda-clearance-how-does-it-work-article-155981553" data-type="tilCustomLink">Eli Lilly</a> as a once-weekly injection. Unlike existing GLP-1 medicines like semaglutide and tirzepatide, it simultaneously targets three hormone pathways --- GLP-1, GIP and glucagon. The combination is developed to target appetite, blood sugar regulation and energy metabolism simultaneuously. 

Lilly's latest Phase 3 results have shown substantial weight loss. In one trial involving people with obesity or overweight and type 2 diabetes, participants receiving the highest studied dose lost an average of 20.8% of their body weight after 80 weeks. 

Another Phase 3 trial reported average weight loss of up to 22.6% after 80 weeks in people with severe obesity and cardiovascular disease. 

But promising results do not mean the medicine is ready for unrestricted use, especially before clearance. Its unapproved status indicates that researchers are still examining the drug for potential side-effects and other complications. 

Lilly says retatrutide remains an investigational medicine and is legally available only to participants in its clinical trials. The company plans to submit it to the <a href="https://www.healthandme.com/health-news/entirely-unverified-retatrutide-being-sold-on-black-market-lilly-sues-6-companies-article-155602507" data-type="tilCustomLink">FDA </a> in the first quarter of 2027. 

<h2>Why Are People Being Hospitalised? </h2>

Also read: <a href="https://www.healthandme.com/health-wellness/ideal-time-to-undergo-fertility-treatment-for-women-taking-glp-1-weight-loss-medications-article-155927744" data-type="tilCustomLink">Ideal Time to Undergo Fertility Treatment for Women Taking GLP-1 Weight-Loss Medications </a> 

The Irish warning is particularly concerning as people obtaining retatrutide outside clinical trials may not have an idea about what they are actually injecting, how concentrated the drug is or whether it has been manufactured and stored safely. 

Prof O'Shea highlighted cases involving nausea, vomiting and kidney problems. He said, "We had somebody in at the weekend who was getting. Retatrutide twice a week in the gym they go to from their personal trainer and they were in hospital with vomiting and <a href="https://www.healthandme.com/health-wellness/what-happens-when-kidney-function-declines-understanding-the-stages-of-chronic-kidney-disease-article-155970689" data-type="tilCustomLink">kidney disease</a>. That’s going to happen widescale if people are taking this drug."

Severe vomiting can itself become dangerous because prolonged fluid loss can cause dehydration and acute kidney injury, particularly when someone is unable to keep fluids down. 

<h2>Growing Concern Of Black Markets </h2>

Healthy and Hearty Picks: Cancer Cases Rising in India | Causes, New Treatments & Prevention

Retatrutide's impressive weight-loss results have fuelled demand for it even though it has not been approved by the <span>FDA</span>. Recent reports spark concerns of a growing black market for the drug, with products being promoted through social media, online sellers, fitness communities and some unregulated clinics. <span>Eli Lilly</span> has taken legal action against companies accused of selling unauthorised retatrutide products. 

This is particularly concerning because buyers may mistake a product marketed as “research use only” for a medicine that is safe for human injection. The HSE is urging people not to use retatrutide obtained outside a legitimate clinical trial. 

Anyone experiencing severe vomiting, abdominal symptoms, weakness, reduced urination or other concerning symptoms after taking an unapproved weight-loss injection should seek medical attention and tell doctors exactly what they have taken.

Health Conditions A-Z

health

unapproved-weight-loss-drug-caused-hospitalisations-in-ireland-what-is-retatrutide-why-is-it-risky

Retatrutide

Retatrutide black market

eli lillys foundayo launched

eli lilly

Retatrutide symptoms

glp 1

glp 1 drugs

glp 1 medication

glp 1 weight loss

h1n1-and-sudden-vision-changes-when-flu-related-eye-symptoms-need-medical-attention

H1N1 and Sudden Vision Changes: When Flu-Related Eye Symptoms Need Medical Attention

fssai-flags-food-firms-for-misleading-100-energy-drink-immunity-claims

FSSAI Flags Food Firms For Misleading ‘100%’, ‘Energy Drink’, Immunity Claims

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Irish health authorities are warning people against using retatrutide, an experimental weight-loss drug that has led to multiple cases of hospitalisation after people obtained it outside legitimate clinical trials through unlawful sources.The warning comes as demand for the drug has grown online, particularly through fitness networks. Despite retatrutide not yet being approved, the masses have been reported to obtain and administer it without medical supervision. Ireland's Health Service Executive (HSE) has reported patients presenting with serious side effects after taking the drug, including severe vomiting and kidney problems. Prof Donal O'Shea, HSE Clinical Lead for Obesity, said doctors are seeing patients who have taken retatrutide obtained through unofficial channels. He said, "Personal trainers who have been giving these jabs give no advice about side effects and how to manage those side effects, leading to real problems".He also warned that some people are choosing not to disclose this information to the healthcare professionals, which has been making it harder to identify the cause of their symptoms and administer appropriate treatment. He added, “They are too embarrassed to say they are taking it, leaving us blindfolded when we are trying to come to a conclusion.”Retatrutide Is An Unapproved Experimental Drug Also read: Eli Lilly’s Foundayo Launched In UK: Is the GLP-1 Pill Better Than Wegovy, Mounjaro?Retatrutide is currently being developed by Eli Lilly as a once-weekly injection. Unlike existing GLP-1 medicines like semaglutide and tirzepatide, it simultaneously targets three hormone pathways --- GLP-1, GIP and glucagon. The combination is developed to target appetite, blood sugar regulation and energy metabolism simultaneuously. Lilly's latest Phase 3 results have shown substantial weight loss. In one trial involving people with obesity or overweight and type 2 diabetes, participants receiving the highest studied dose lost an average of 20.8% of their body weight after 80 weeks. Another Phase 3 trial reported average weight loss of up to 22.6% after 80 weeks in people with severe obesity and cardiovascular disease. But promising results do not mean the medicine is ready for unrestricted use, especially before clearance. Its unapproved status indicates that researchers are still examining the drug for potential side-effects and other complications. Lilly says retatrutide remains an investigational medicine and is legally available only to participants in its clinical trials. The company plans to submit it to the FDA  in the first quarter of 2027. Why Are People Being Hospitalised? Also read: Ideal Time to Undergo Fertility Treatment for Women Taking GLP-1 Weight-Loss Medications  The Irish warning is particularly concerning as people obtaining retatrutide outside clinical trials may not have an idea about what they are actually injecting, how concentrated the drug is or whether it has been manufactured and stored safely. Prof O'Shea highlighted cases involving nausea, vomiting and kidney problems. He said, "We had somebody in at the weekend who was getting. Retatrutide twice a week in the gym they go to from their personal trainer and they were in hospital with vomiting and kidney disease. That’s going to happen widescale if people are taking this drug."Severe vomiting can itself become dangerous because prolonged fluid loss can cause dehydration and acute kidney injury, particularly when someone is unable to keep fluids down. Growing Concern Of Black Markets                Retatrutide's impressive weight-loss results have fuelled demand for it even though it has not been approved by the FDA. Recent reports spark concerns of a growing black market for the drug, with products being promoted through social media, online sellers, fitness communities and some unregulated clinics. Eli Lilly has taken legal action against companies accused of selling unauthorised retatrutide products. This is particularly concerning because buyers may mistake a product marketed as “research use only” for a medicine that is safe for human injection. The HSE is urging people not to use retatrutide obtained outside a legitimate clinical trial. Anyone experiencing severe vomiting, abdominal symptoms, weakness, reduced urination or other concerning symptoms after taking an unapproved weight-loss injection should seek medical attention and tell doctors exactly what they have taken.

unapproved weight-loss drug caused hospitalisations in ireland: what is retatrutide & why is it risky?

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Unapproved Weight-Loss Drug Caused Hospitalisations In Ireland: What Is Retatrutide & Why Is It Risky?

FSSAI Flags Food Firms For Misleading ‘100%’, ‘Energy Drink’, Immunity Claims

PM2.5 Linked To 8.82 Million Global Cancer Cases, Accounts for Largest Share Among Pollutants: Study

Tivicay: US FDA Approves Drug to Treat HIV In Newborns

Health Conditions A-Z

H1N1 and Sudden Vision Changes: When Flu-Related Eye Symptoms Need Medical Attention

Unapproved Weight-Loss Drug Caused Hospitalisations In Ireland: What Is Retatrutide & Why Is It Risky?

FSSAI Flags Food Firms For Misleading ‘100%’, ‘Energy Drink’, Immunity Claims